Press Releases

Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008 FORD, Mass., May 15 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), a leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, today announced the

Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008 FORD, Mass., May 15 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), a leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, today announced the

1,200 New Patients Shipped in the Quarter Production Increases to 95,000 OmniPods per Month Salesforce Expands to Cover All 50 States

Insulet Corporation to Report First Quarter 2008 Financial Results on Tuesday, May 13, 2008 BEDFORD, Mass., April 23 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, announced plans to release

OmniPod Customer Base More Than Tripled in 2007 Gross Loss Improved Significantly over Third Quarter 2007

Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17 BEDFORD, Mass., Feb. 20 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, announced plans

Insulet Corporation to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 7, 2008 BEDFORD, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in wearable insulin pump technology with its OmniPod ® Insulin

Insulet's OmniPod(R) Personal Diabetes Manager to Integrate DexCom Continuous Glucose Monitoring Technology

Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008 BEDFORD, Mass., Jan 02, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that

OmniPod Customer Base Grows over 30% in Third Quarter Production Increases to 45,000 OmniPods per Month

Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, announced plans to release its financial

Insulet Corporation Announces Pricing of Secondary Public Offering BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced the pricing of its public offering of 4,898,398 shares

Insulet Corporation Announces Proposed Secondary Public Offering of Common Stock BEDFORD, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, announced today that it has filed a registration statement

Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program BEDFORD, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the maker of the OmniPod ® Insulin Management System, today announced that it has been awarded a home medical

Insulet Corporation to Present at the William Blair Small Cap Growth Conference on October 3, 2007 BEDFORD, Mass., Sept. 26 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that Duane DeSisto,